The ASHG president offers some meeting highlights and what she will be looking forward to next week in Boston.

Preclinical data demonstrates that Shape’s engineered AAV5 variant, SHP-DB1, efficiently targets the NHP brain after ...

Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.

The Slope Sea off the Northeast U.S. coast has been studied over the past decade in the belief it contributes to bluefin tuna ...

AstraZeneca's Oxford COVID-19 vaccine accurately follows the genetic instructions programmed into it by its developers to successfully provoke a strong immune response, according to a detailed ...

U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), a fatal ...

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body ...